"FDA Pulls Heartburn Drug Zantac From Market" — U.S. News & World Report
"Zantac heartburn drug recalled on contamination risk" — Associated Press
"Zantac pulled over cancer risk" — USA Today
"Zantac Products Should Not Be Sold or Used, FDA Warns" — New York Times
FREE CASE EVALUATION
SOMEONE YOU KNOW
been diagnosed with cancer after using Zantac?
Find out if you qualify for compensation in 3 simple steps for your peace of mind.
By clicking “Submit” I consent to receive calls, text messages, or prerecorded messages from
Consumer Attention or its affiliates via automated technology. I understand that I am not required
to enter into this agreement as a condition of any service.
If you believe you’ve reached this page in error or would like to opt-out of future correspondence, please
N-nitrosodimethylamine (NDMA) is listed by the International Agency for Research on Cancer (IARC) as a compound that is
probably carcinogenic to humans, and by the U.S. National Toxicology Program (NTP) as a compound reasonably anticipated to
be a human carcinogen. In fact, NDMA is actually used in the research laboratory setting to induce cancer in rats.